The data presented support use of MR vaccine at 6 months to protect young infants during measles outbreaks and in settings ...

UTRECHT, The Netherlands and CAMBRIDGE, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), an oncology company developing ...

Led by a team of distinguished toxicology experts, TriApex was thrilled to take part in this prestigious meeting, engaging in ...

Mucormycosis, a fungal infection caused by Mucorales, has high mortality rates in people with weakened immune systems and ...

The live vaccine is produced from the strain Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN), an attenuated, non-replicating orthopoxvirus.

As a result, Ibrahim and Gu developed an antibody called VX-01, a humanized antibody that has proven more effective at ...

Single IV administration of tau silencing gene therapy VY1706 significantly reduced tau mRNA and protein levels, with broad brain distribution and liver ...